DK325486A - Fremgangsmaade til fremme af bakteriers vedhaeftning til mave-tarmkanali dyr og mennesker samt praeparat til anvendelse ved fremgangsmaaden - Google Patents

Fremgangsmaade til fremme af bakteriers vedhaeftning til mave-tarmkanali dyr og mennesker samt praeparat til anvendelse ved fremgangsmaaden Download PDF

Info

Publication number
DK325486A
DK325486A DK325486A DK325486A DK325486A DK 325486 A DK325486 A DK 325486A DK 325486 A DK325486 A DK 325486A DK 325486 A DK325486 A DK 325486A DK 325486 A DK325486 A DK 325486A
Authority
DK
Denmark
Prior art keywords
procedure
bacteria
humans
animals
adherence
Prior art date
Application number
DK325486A
Other languages
English (en)
Other versions
DK172252B1 (da
DK325486D0 (da
Inventor
Staffan Kjelleberg
Patricia Conway
Original Assignee
Chemical Dynamics Sweden Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemical Dynamics Sweden Ab filed Critical Chemical Dynamics Sweden Ab
Publication of DK325486D0 publication Critical patent/DK325486D0/da
Publication of DK325486A publication Critical patent/DK325486A/da
Application granted granted Critical
Publication of DK172252B1 publication Critical patent/DK172252B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Feed For Specific Animals (AREA)
DK325486A 1984-11-08 1986-07-08 Præparat til fremme af vedhæftningen af bakterier til mave-tarmkanal i mennesker og dyr samt fremgangsmåde til fremstilling af et protein med samme egenskaber DK172252B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE8405587A SE463598B (sv) 1984-11-08 1984-11-08 Preparat, avsett att oeka vidhaeftningen av bakterier till mag-tarmkanalen hos maenniskor och djur, samt ett framstaellningsfoerfarande foer detta
SE8405587 1984-11-08
PCT/SE1985/000431 WO1986002837A1 (en) 1984-11-08 1985-11-05 A method of binding microflora and preparations therefor
SE8500431 1985-11-05

Publications (3)

Publication Number Publication Date
DK325486D0 DK325486D0 (da) 1986-07-08
DK325486A true DK325486A (da) 1986-07-08
DK172252B1 DK172252B1 (da) 1998-02-09

Family

ID=20357659

Family Applications (1)

Application Number Title Priority Date Filing Date
DK325486A DK172252B1 (da) 1984-11-08 1986-07-08 Præparat til fremme af vedhæftningen af bakterier til mave-tarmkanal i mennesker og dyr samt fremgangsmåde til fremstilling af et protein med samme egenskaber

Country Status (11)

Country Link
US (1) US4767623A (da)
EP (1) EP0201579B1 (da)
JP (1) JPH0720876B2 (da)
AT (1) ATE81290T1 (da)
CA (1) CA1266234A (da)
DE (1) DE3586744T2 (da)
DK (1) DK172252B1 (da)
ES (2) ES8700938A1 (da)
FI (1) FI85810C (da)
SE (1) SE463598B (da)
WO (1) WO1986002837A1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804179A (en) * 1985-12-31 1998-09-08 Research Corporation Technologies, Inc. Lactobacillus compositions and methods for treating urinary tract infections
SE8900546D0 (sv) * 1989-02-17 1989-02-17 Bioinvent Int Ab Medel foer inhibering av patogeners adhesion tillvaext och /eller oeverlevnad
IL101410A0 (en) * 1992-03-29 1992-11-15 Era Masis Ltd Formulation for the treatment of cancer
AUPM823094A0 (en) * 1994-09-16 1994-10-13 Goodman Fielder Limited Probiotic compositions
JP3819441B2 (ja) * 1997-01-09 2006-09-06 森永乳業株式会社 ラクトフェリン錠剤
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
AU4059999A (en) * 1998-06-05 1999-12-30 Wakamoto Pharmaceutical Co., Ltd. Lactic acid bacterium-containing compositions, drugs and foods
US6645515B1 (en) * 1998-11-26 2003-11-11 Meito Sangyo Kabushiki Kaisha Bacteriostatic composition for salmonellae
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US7785635B1 (en) * 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050152884A1 (en) * 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
MX2007012755A (es) * 2005-04-15 2008-01-14 Univ North Carolina State Metodos y composiciones para modular la adhesion y tolerancia al estres en bacterias.
CA2607949C (en) * 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Feline probiotic bifidobacteria
AR052472A1 (es) * 2005-05-31 2007-03-21 Iams Company Lactobacilos probioticos para felinos
AU2008211600B8 (en) 2007-02-01 2014-02-13 Mars, Incorporated Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL294835A (da) * 1962-07-19 1900-01-01
SE371209B (da) * 1969-10-13 1974-11-11 Cernelle Ab
JPS52102419A (en) * 1976-02-23 1977-08-27 Seikenkai Lactic acid producing bacillus preparation
DE2738652C3 (de) * 1977-08-26 1981-02-19 Seiken Kai Foundation Juridical Person, Tondabayashi, Osaka (Japan) Lactobacillus-Präparat und seine Verwendung bei der Bekämpfung bakterieller Infektionen und Entzündungen
CH637297A5 (fr) * 1978-12-05 1983-07-29 Nestle Sa Microbille comprenant un microorganisme et son procede de fabrication.
FI59925C (fi) * 1980-01-11 1981-11-10 Esko Viljo Nurmi Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae
JPS5810520A (ja) * 1981-07-10 1983-01-21 Miyarisan Kk 胆石症の治療薬
JPS5911177A (ja) * 1982-07-12 1984-01-20 Seikenkai 新規乳酸桿菌
SE8206250L (sv) * 1982-11-03 1984-05-04 Chemical Dynamics Sweden Ab Reglering av tarmmikroflora

Also Published As

Publication number Publication date
FI85810B (fi) 1992-02-28
DE3586744D1 (de) 1992-11-12
US4767623A (en) 1988-08-30
EP0201579A1 (en) 1986-11-20
JPH0720876B2 (ja) 1995-03-08
DE3586744T2 (de) 1993-04-01
ES557029A0 (es) 1987-05-16
JPS62500722A (ja) 1987-03-26
ES8700938A1 (es) 1986-11-16
SE8405587D0 (sv) 1984-11-08
AU5097285A (en) 1986-06-03
EP0201579B1 (en) 1992-10-07
FI862863A (fi) 1986-07-07
FI85810C (fi) 1992-06-10
ES8705229A1 (es) 1987-05-16
CA1266234A (en) 1990-02-27
SE8405587L (sv) 1986-05-09
ATE81290T1 (de) 1992-10-15
WO1986002837A1 (en) 1986-05-22
AU589384B2 (en) 1989-10-12
ES549313A0 (es) 1986-11-16
FI862863A0 (fi) 1986-07-07
DK172252B1 (da) 1998-02-09
DK325486D0 (da) 1986-07-08
SE463598B (sv) 1990-12-17

Similar Documents

Publication Publication Date Title
DK325486A (da) Fremgangsmaade til fremme af bakteriers vedhaeftning til mave-tarmkanali dyr og mennesker samt praeparat til anvendelse ved fremgangsmaaden
DK0731699T3 (da) Fremgangsmåde til reduktion af legemsfedt i dyr ved indgivelse af konjugeret linolsyre
FI893702A (fi) Foerfarande foer mikrobiologisk framstaellning av humant serumalbumin och andra heterologa proteiner ur jaest.
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
ATE95564T1 (de) Aeusseres membranprotein f von pseudomonas aeruginosa.
AU5415390A (en) Vaccines for combatting septicemic bacteria
IT8483359A0 (it) Procedimento per ottenere lapreparazione di concentrati e nutrimenti proteici dal sangue animale.
ATE43500T1 (de) Herstellung von antikoerpern.
PT86552A (de) Gama-glutamyl-transpeptidase deren herstellung und deren verwendung
ATE112320T1 (de) Sekretormutante von escherichia coli.
ATE78403T1 (de) Impfstoff gegen mastitis.
GR860329B (en) Reagent for the dosage of antibodies against bacteric toxines by hemaglutination method for preparation and application thereof
ES2016227A4 (es) 54- procedimiento para la elaboracion de aminoacidos l-alfa.
FI881122A (fi) Menetelmä tyvikalvoproteiinien eristämiseksi ihmis- ja eläinkudoksista
KR880013575A (ko) 안정한 동결건조된 생체 헤르페스 바이러스 백신
DK142380A (da) Fremgangsmaade til fremstilling af pentadecapeptider
Heringova et al. Sulfate metabolism in the intestinal mucosa of weanling and adult rats
FR2589063B1 (fr) Procede de culture de babesia canis, application a la preparation d'antigenes et de vaccins, et antigenes et vaccins contre la piroplasmose
DK183788D0 (da) Fremgangsmaade til foroegelse af levedygtigheden af frysetoerrede, maelkesyreproducerende bakteriekulturkoncentrater
SE8600987L (sv) Forfarande for framstellning av ett protein- koncentrat ur helblod
Chalifoux et al. Enzymes Sériques pour le Diagnostic de la Nécrose Hépatique Aigüe Expérimentale
PH19648A (en) Detoxified e.coli neurotoxin,preparation thereof and immunological preparations containing it
FI905247A0 (fi) Dietmaterial.
Chalifoux et al. Serum enzymes for the diagnosis of experimental acute hepatic necrosis

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed